# Avera Cancer Sequencing and Analytics Protocol (ASAP)

> **NCT05142033** · — · RECRUITING · sponsor: **Avera McKennan Hospital & University Health Center** · enrollment: 25000 (estimated)

## Conditions studied

- Cancer
- Cancer Diagnosis
- Early Detection of Cancer
- Breast Cancer
- Lung Cancer
- Colon Cancer
- GI Cancer
- Gynecologic Cancer
- Ovarian Cancer
- Endometrial Cancer
- CNS Cancer
- Hematologic Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05142033
- **Lead sponsor:** Avera McKennan Hospital & University Health Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-11-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 25000 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05142033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05142033, "Avera Cancer Sequencing and Analytics Protocol (ASAP)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05142033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*